BioTime (BTX) Reports Q4 Loss of $0.58/Share

BioTime (NYSE: BTX) reported Q4 EPS of ($0.58), versus ($0.05) reported last year. Revenue for the quarter came in at $1 million, versus $1.1 million reported last year.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• HSBC Upgrades Capital One Financial (COF) to Buy
• Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook